Celltrion Pharm Inc (068760) — Cash Flow Reinvestment Rate
Celltrion Pharm Inc (068760) has a Cash Flow Reinvestment Rate of 0.95x as of September 2025, reinvesting ₩22.17 Billion (capex ₩2.27 Billion plus investments ₩-19.90 Billion) from operating cash flow of ₩23.44 Billion. See 068760 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celltrion Pharm Inc Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Celltrion Pharm Inc across 8 annual periods. For the full cash flow conversion analysis, see 068760 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Celltrion Pharm Inc (2014–2024)
Year-by-year capital reinvestment analysis for Celltrion Pharm Inc. See Celltrion Pharm Inc (068760) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | ₩18.10 Billion | ₩56.59 Billion | ₩5.98 Billion | ▼ -74.8% |
| 2023 | 1.27x | ₩11.12 Billion | ₩8.76 Billion | ₩6.90 Billion | ▲ +310.6% |
| 2021 | 0.31x | ₩28.81 Billion | ₩93.15 Billion | ₩12.50 Billion | ▼ -73.7% |
| 2020 | 1.18x | ₩42.61 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -0.9% |
| 2019 | 1.19x | ₩33.06 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +125.8% |
| 2018 | 0.53x | ₩7.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -85.2% |
| 2015 | 3.55x | ₩47.38 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +131.5% |
| 2014 | 1.53x | ₩26.53 Billion | ₩17.33 Billion | ₩26.16 Billion | — |